Acadia Healthcare Company Inc (ACHC)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Acadia Healthcare Company Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 9 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 29.60 $ — 75% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 8.3% failed
- More than 10% revenue growth is expected for the coming year 6.0% failed
- Share count grows by less than 3% a year -0.3% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -8.2% failed
- Gross margin at 40% or higher and without meaningful erosion 17.6% failed
- Goodwill from acquisitions does not grow faster than revenue 23.5% passed
- Net debt below twice EBITDA failed
- Operating cash flow covers the profits of the last three years 1,593 m passed
- Return on capital at 15% or higher, or up versus two years ago 7.8% failed
- Insiders hold at least 10% or are net buyers 1.6% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 12.8% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 14
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.55 | 1.48 – 1.59 | 3,428 | -22.5% | 12 |
| 12/31/2027 | 1.82 | 1.63 – 1.98 | 3,628 | 17.5% | 12 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.48 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.35 | -43.60 | 774 | 4.20 | 4.20 | 117 | -87 |
| 2025: Q1 | 0.09 | -89.00 | 771 | 0.30 | 1.10 | 12 | -163 |
| 2025: Q2 | 0.33 | -60.90 | 869 | 9.20 | 3.50 | 134 | -34 |
| 2025: Q3 | 0.40 | -45.90 | 852 | 4.40 | 4.30 | 73 | -63 |
| 2025: Q4 | -13.02 | -3,772.00 | 822 | 6.10 | -143.30 | -86 | -180 |
| 2026: Q1 | 0.05 | -50.30 | 829 | 7.60 | 0.50 | 62 | -15 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 2,811 | 445 | 6 | 0.07 | 361 | 2,168 | 6,025 |
| 2017 | 2,836 | 438 | 200 | 2.30 | 400 | 2,573 | 6,425 |
| 2018 | 3,012 | 413 | -176 | -2.01 | 414 | 2,333 | 6,173 |
| 2019 | 2,008 | 662 | 109 | 1.24 | 333 | 2,505 | 6,879 |
| 2020 | 2,090 | 366 | -672 | -7.59 | 659 | 1,899 | 6,499 |
| 2021 | 2,314 | 414 | 191 | 2.10 | 374 | 2,517 | 4,768 |
| 2022 | 2,610 | 468 | 273 | 2.98 | 381 | 2,813 | 4,988 |
| 2023 | 2,929 | 507 | -22 | -0.24 | 462 | 2,782 | 5,359 |
| 2024 | 3,154 | 522 | 256 | 2.78 | 130 | 3,074 | 5,957 |
| 2025 | 3,313 | 388 | -1,103 | -12.16 | 132 | 1,949 | 5,527 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Acadia Healthcare Company, Inc. bietet Verhaltensgesundheitsdienste in den USA und Puerto Rico an.
| Employees | 25,000 |
|---|---|
| Headquarters | Franklin, TN |
| Address | 4020 Aspen Grove Drive, 37067 Franklin, United States |
| Phone | 615 861 6000 |
| Website | acadiahealthcare.com |
| IPO Date | 4. Mar 1994 |
| ISIN | US00404A1097 |
| Stock Split | 1:4 on 11/01/2011 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Brian P. Farley Esq., J.D. | Executive VP, General Counsel & Secretary | 1970 |
| Timothy Sides | Senior Vice President of Operations Finance | 1978 |
| Debra K. Osteen | CEO & Director | 1956 |
| David M. Duckworth | Interim Chief Financial Officer | 1980 |
| Patrick Thomas Feeley C.F.A., CPA | Senior Vice President of Investor Relations | – |
| Jeffrey Woods | Operations Group President | – |
| Steve Quigley | Group President of Specialty Division | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 26. Jul 2026 | Farley Brian | EVP, CLAO and Secretary | Other | 1,770 | 34.51 | 61,083 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.